載入中
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
前收盤價
US$0.37
+US$0.0007 · +0.19%
盤中時間採用ET。市場資料可能有所延遲。
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
日內區間
目前US$0.37
52週區間
目前US$0.37
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
賣出
估值
44
合理估值
情緒
50
多空交錯
風險
67
高風險
動能
20
強勢下行
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
日內區間
目前US$0.37
52週區間
目前US$0.37
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | 485.63萬 USD | 337.1萬 USD | 240.36萬 USD | 359.48萬 USD | — |
| 銷貨成本 | 329.8萬 USD | 206.98萬 USD | 180.46萬 USD | 161.77萬 USD | — |
| 毛利 | 155.83萬 USD | 130.13萬 USD | 59.89萬 USD | 197.71萬 USD | — |
| 銷售、一般及管理費用 | 370.33萬 USD | 267.43萬 USD | 209.05萬 USD | 2609.02萬 USD | 13.56萬 USD |
| 營業費用 | 493.93萬 USD | 380.28萬 USD | 300.81萬 USD | 251.26萬 USD | 13.56萬 USD |
| 利息收入 | 3856 USD | 123 USD | — | — | 99 USD |
| 利息支出 | 5.05萬 USD | 4.83萬 USD | 4.28萬 USD | 4.66萬 USD | — |
| 折舊和攤銷 | 112.95萬 USD | 112.85萬 USD | 90.34萬 USD | 89.86萬 USD | — |
| 營業利益 | −338.1萬 USD | −250.15萬 USD | −240.91萬 USD | −53.55萬 USD | −13.56萬 USD |
| 淨利 | −200.84萬 USD | −251.36萬 USD | −230.4萬 USD | −72.92萬 USD | −11.96萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
